Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Marie Pierre Moles-Moreau"'
Autor:
Pierre Walczak, Sylvain Choquet, Jacques Dantal, David Boutboul, Felipe Suarez, Marine Baron, Veronique Morel, Thomas Cluzeau, Mohamed Touati, Michelle Elias, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, Roch Houot, Geoffroy Venton, Caroline Jacquet, Marie-Pierre Moles-Moreau, Fabrice Jardin, Eric Durot, Noureddine Balegroune, Laure Ecotiere, Romain Guieze, Nassim Kamar, Loic Ysebaert, Lionel Couzi, Hugo Gonzalez, Louise Roulin, Kevin Ou, Sophie Caillard, Heiner Zimmermann, Ralf Ulrich Trappe, Damien Roos-Weil
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Externí odkaz:
https://doaj.org/article/4fd7c8f1bf3843ebbe6d2663de488a3d
Autor:
Matthew R. Wilson, Toby A. Eyre, Amy A. Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Nicolás Martinez-Calle, Gavin Preston, Matthew Ahearne, Elisabeth Schorb, Marie-Pierre Moles-Moreau, Matthew Ku, Chiara Rusconi, Jahanzaib Khwaja, Mayur Narkhede, Katharine L. Lewis, Teresa Calimeri, Eric Durot, Loïc Renaud, Andreas Kiesbye Øvlisen, Graham McIlroy, Timothy J. Ebsworth, Johnathan Elliot, Anna Santarsieri, Laure Ricard, Nimish Shah, Qin Liu, Adam S. Zayac, Francesco Vassallo, Laure Lebras, Louise Roulin, Naelle Lombion, Kate Manos, Ruben Fernandez, Nada Hamad, Alberto Lopez-Garcia, Deirdre O'Mahony, Praveen Gounder, Nathalie Forgeard, Charlotte Lees, Kossi Agbetiafa, Tim Strüßmann, Thura Win Htut, Aline Clavert, Hamish Scott, Anna Guidetti, Brett R. Barlow, Emmanuelle Tchernonog, Jeffery Smith, Fiona Miall, Christopher P. Fox, Chan Y. Cheah, Tarec Christoffer El Galaly, Andrés J. M. Ferreri, Kate Cwynarski, Pamela McKay
Publikováno v:
Wilson, M R, Eyre, T A, Kirkwood, A A, Wong Doo, N, Soussain, C, Choquet, S, Martinez-Calle, N, Preston, G, Ahearne, M J, Schorb, E, Moles-Moreau, M-P, Ku, M, Rusconi, C, Khwaja, J, Narkhede, M, Lewis, K L, Calimeri, T, Durot, E, Renaud, L, Øvlisen, A K, Mcilroy, G, Ebsworth, T J, Elliot, J, Santarsieri, A, Ricard, L, Shah, N, Liu, Q, Zayac, A S, Vassallo, F, Lebras, L, Roulin, L, Lombion, N, Manos, K, Fernandez, R, Hamad, N, Lopez-Garcia, A, O'Mahony, D, Gounder, P, Forgeard, N, Lees, C, Agbetiafa, K, Strüessmann, T, Htut, T W, Clavert, A, Scott, H, Guidetti, A, Barlow, B R, Tchernonog, E, Smith, J, Miall, F, Fox, C P, Cheah, C Y, El Galaly, T C, Ferreri, A J M, Cwynarski, K & McKay, P 2022, ' Timing of high dose methotrexate CNS prophylaxis in DLBCL : a multicenter international analysis of 1,384 patients ', Blood, vol. 139, no. 16, pp. 2499-2511 . https://doi.org/10.1182/blood.2021014506
Prophylactic high-dose methotrexate (HD-MTX) is often used for diffuse large B-cell lymphoma (DLBCL) patients at high risk of central nervous system (CNS) relapse, despite limited evidence demonstrating efficacy or the optimal delivery method. We con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::906a66418f9b1bfafd3fd14b33943dce
https://vbn.aau.dk/da/publications/4c8d4993-b73b-4f50-a5d0-8e283e951137
https://vbn.aau.dk/da/publications/4c8d4993-b73b-4f50-a5d0-8e283e951137
Autor:
Romain-David Seban, Anna Schmitt, Aiping Chen, Guillaume Manson, Jean-Marc Schiano de Colella, Lawrence H. Schwartz, Olivier Casasnovas, Fatima-Zohra Mokrane, Laurent Dercle, Apasia Stamatoullas, Laetitia Vercellino, Roch Houot, Remy Dulery, Marie-Pierre Moles-Moreau, Hervé Ghesquières, Frederic Peyrade, Emmanuelle Nicolas-Virelizier, Mohamed Touati, Franck Morschhauser, Adrien Chauchet, Krimo Bouabdallah, Benedicte Deau-Fischer, Cécile Borel, Alain Delmer
Publikováno v:
Radiology. 295:651-661
Background CT and fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/CT performances following immune therapy are not well known in patients with relapsed or refractory Hodgkin lymphoma (RRHL). Purpose To compare CT and PET/CT for prognostic value of ear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a61eb2081907387cd88b8734ab2afbc0
https://doi.org/10.1148/radiol.2020192056
https://doi.org/10.1148/radiol.2020192056
Autor:
Cédric Rossi, Kamel Laribi, Alexandra Traverse-Glehen, Fabrice Jardin, Roch Houot, Alexandre Willaume, Martin Gauthier, Sophie Bernard, David Tonnelet, Katell Le Du, Gandhi Damaj, Pierre Sesques, Magalie Pascale Tardy, Julien Lazarovici, Hélène Monjanel, Hervé Tilly, Laure Lebras, Corinne Haioun, Adrien Chauchet, Chloe Antier, Alina Berriolo-Riedinger, Caroline Besson, Herve Gerard Maisonneuve, Vincent Camus, Christophe Bonnet, Justine Lequesne, Eric Durot, Sylvain Choquet, Stéphanie Becker, Sarah Bailly, Marie-Pierre Moles-Moreau, Pierre Decazes
Publikováno v:
Blood Adv
Blood advances, Vol. 5, no. 19, p. 3862-3872 (2021)
Blood advances, Vol. 5, no. 19, p. 3862-3872 (2021)
Primary mediastinal B-cell lymphoma (PMBL) is a rare type of aggressive lymphoma typically affecting young female patients. The first-line standard of care remains debated. We performed a large multicenter retrospective study in 25 centers in France
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02aae272ce0ecca7c91653bb98154697
https://europepmc.org/articles/PMC8679665/
https://europepmc.org/articles/PMC8679665/
Autor:
Didier Blaise, Tycel Phillips, Jason T. Romancik, Roch Houot, Robert Lowsky, Martina Sollini, Jean Marc Schiano De Colella, Amer Beitinjaneh, Gunjan L. Shah, Lazaros J. Lekakis, Stephen D. Smith, Paolo Corradini, Mohamad Mohty, Maryam Rahimian, Luca Castagna, Taiga Nishihori, Asad Bashey, Talha Badar, Reid W. Merryman, Mehdi Hamadani, Carmelo Carlo-Stella, Dipenkumar Modi, Sally Arai, Kamal Bouabdallah, Valter Torri, Joseph P. McGuirk, Guillaume Manson, Anna Guidetti, Yi-Bin Chen, Hatcher J. Ballard, Julio C. Chavez, Pier Luigi Zinzani, Tatyana Feldman, Sunita Nathan, Anurag K. Singh, Massimo Magagnoli, Marie Pierre Moles-Moreau, Beatrice Casadei, Anthony Serritella, Michael Byrne, Radhakrishnan Ramchandren, Miguel-Angel Perales, Chiara De Philippis, Samantha Jaglowski, Justin Kline, Remy Dulery, Laura Giordano, Alex F. Herrera, Jonathon B. Cohen, Philippe Armand, Armando Santoro, Aspasia Stamatoulas, Stephen M. Ansell, Michael A. Spinner, Lori Dahncke, Corentin Orvain, Chloé Spilleboudt, Geoffrey Shouse, Robin Joyce, Vincent T. Ho, Matthew J. Frigault, Ryan C. Lynch, Uttam Rao, Jakub Svoboda, David A. Bond, Yago Nieto
Publikováno v:
Leukemia
Leukemia, 2021, 35 (9), pp.2672-2683. ⟨10.1038/s41375-021-01193-6⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2021, 35 (9), pp.2672-2683. ⟨10.1038/s41375-021-01193-6⟩
Leukemia, 2021, 35 (9), pp.2672-2683. ⟨10.1038/s41375-021-01193-6⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2021, 35 (9), pp.2672-2683. ⟨10.1038/s41375-021-01193-6⟩
International audience; Anti-PD-1 monoclonal antibodies yield high response rates in patients with relapsed/refractory classic Hodgkin lymphoma (cHL), but most patients will eventually progress. Allogeneic hematopoietic cell transplantation (alloHCT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35becb5c5a55058afd6585d16fefe3a8
https://univ-rennes.hal.science/hal-03229516
https://univ-rennes.hal.science/hal-03229516
Autor:
Alain Delmer, Laurent Dercle, Guillaume Manson, Frederic Peyrade, Mohamed Touati, Romain-David Seban, Krimo Bouabdallah, Laetitia Vercellino, Aiping Chen, Adrien Chauchet, Roch Houot, Marie-Pierre Moles-Moreau, Anna Schmitt, Philippe Armand, Lawrence H. Schwartz, Cécile Borel, Emmanuelle Nicolas-Virelizier, Hervé Ghesquières, Remy Dulery, Franck Morschhauser, Benedicte Deau-Fischer, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Fatima-Zohra Mokrane, Olivier Casasnovas
Publikováno v:
Journal of Nuclear Medicine. 61:649-654
Monoclonal antibodies (mAbs) against programmed cell death 1 (PD-1), such as nivolumab and pembrolizumab, are associated with high response rates in patients with relapsed or refractory classic Hodgkin lymphoma (HL). To date, no prognostic factor for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f46b6ae91944bae95cc704d78e28b63a
https://doi.org/10.2967/jnumed.119.232827
https://doi.org/10.2967/jnumed.119.232827
Autor:
Jonathan Farhi, Jérôme Paillassa, Aurelien Giltat, Emmanuel Gyan, Mathilde Hunault-Berger, Tony Marchand, Mélanie Mercier, Marie-Christine Rousselet, Roch Houot, Aline Clavert, Christopher Nunes Gomes, Laurianne Drieu La Rochelle, Marie-Pierre Moles-Moreau, Corentin Orvain
Publikováno v:
Cancers
Volume 13
Issue 12
Cancers, Vol 13, Iss 2945, p 2945 (2021)
Volume 13
Issue 12
Cancers, Vol 13, Iss 2945, p 2945 (2021)
Diffuse large B-cell lymphoma (DLBCL) with extra nodal skeletal involvement is rare. It is currently unclear whether these lymphomas should be treated in the same manner as those without skeletal involvement. We retrospectively analyzed the impact of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f5687d936200e1328735442374d8f63
Autor:
Luc-Matthieu Fornecker, Cécile Chabrot, Marie-Pierre Moles-Moreau, Guido Ahle, Lise Willems, Agathe Waultier-Rascalou, Caroline Houillier, Khê Hoang-Xuan, Carole Soussain
Publikováno v:
Neurology. 97(13)
Background and ObjectivesTo evaluate the efficacy and tolerance of the association rituximab-lenalidomide-ibrutinib (R2I) in relapsed/refractory (R/R) primary CNS lymphoma (PCNSL).MethodsR/R PCNSL patients treated with R2I were retrospectively select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::682daab37c2b70ffd9812881e023b09a
https://pubmed.ncbi.nlm.nih.gov/34580183
https://pubmed.ncbi.nlm.nih.gov/34580183
Autor:
Audrey Letourneau, Philippe Gaulard, Vincent Camus, Olivier Casasnovas, Edoardo Missiaglia, Corinne Haioun, François Lemonnier, Laurent Voillat, Cyrielle Robe, Caroline Régny, Virginie Fataccioli, Violaine Safar, Céline Bossard, Guillaume Cartron, Emmanuel Bachy, Slim Fourati, Michel Meignan, Marie-Pierre Moles-Moreau, Laura Pelletier, Alain Delmer, Asma Beldi-Ferchiou, Victoria Cacheux, Marie Parrens, Stéphanie Becker, Marie-Hélène Delfau-Larue, Anne-Ségolène Cottereau, Reda Bouabdallah, Laurence de Leval
Publikováno v:
Blood advances, vol. 5, no. 2, pp. 539-548
Blood Advances
Blood Advances, The American Society of Hematology, 2021, 5 (2), pp.539-548. ⟨10.1182/bloodadvances.2020003081⟩
Blood Adv
Blood Advances
Blood Advances, The American Society of Hematology, 2021, 5 (2), pp.539-548. ⟨10.1182/bloodadvances.2020003081⟩
Blood Adv
Angioimmunoblastic T-cell lymphoma (AITL) is a frequent T-cell lymphoma in the elderly population that has a poor prognosis when treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) therapy. Lenalidomide, which has been safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe723d9c1c1a08120c1643f7469e319
https://serval.unil.ch/resource/serval:BIB_CB2690885CDD.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_CB2690885CDD.P001/REF.pdf
Autor:
Fatima-Zohra, Mokrane, Aiping, Chen, Lawrence H, Schwartz, Franck, Morschhauser, Apasia, Stamatoullas, Jean-Marc, Schiano de Colella, Laetitia, Vercellino, Olivier, Casasnovas, Adrien, Chauchet, Alain, Delmer, Emmanuelle, Nicolas-Virelizier, Hervé, Ghesquières, Marie-Pierre, Moles-Moreau, Anna, Schmitt, Rémy, Duléry, Krimo, Bouabdallah, Cecile, Borel, Mohamed, Touati, Bénédicte, Deau-Fischer, Frédéric, Peyrade, Romain-David, Seban, Guillaume, Manson, Roch, Houot, Laurent, Dercle
Publikováno v:
Radiology. 295(3)
Background CT and fluorine 18 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bedbe24671432152202ae87b84c0f950
https://pubmed.ncbi.nlm.nih.gov/32293222
https://pubmed.ncbi.nlm.nih.gov/32293222